000			01304 a2200433 4500
005			20250511180521.0
264		0	_c19921223
008			199212s 0 0 eng d
022			_a0315-162X
040			_aNLM _beng _cNLM
100	1		_aSayers, M E
245	0	0	_aInclusion body myositis: analysis of 32 cases. _h[electronic resource]
260			_bThe Journal of rheumatology _cSep 1992
300			_a1385-9 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAzathioprine _xtherapeutic use
650	0	4	_aBiopsy
650	0	4	_aCyclosporine _xtherapeutic use
650	0	4	_aDemography
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInclusion Bodies _xultrastructure
650	0	4	_aMale
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aMuscles _xpathology
650	0	4	_aMyositis _xdrug therapy
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aRetrospective Studies
650	0	4	_aTime Factors
700	1		_aChou, S M
700	1		_aCalabrese, L H
773	0		_tThe Journal of rheumatology _gvol. 19 _gno. 9 _gp. 1385-9
999			_c1337963 _d1337963